Experience with implantable cardioverter-defibrillator therapy in grown-ups with congenital heart disease

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue SUPPL. 1, 2008, Pages

  Tomaske, Maren ^a   Bauersfeld, Urs ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Complications; Congenital heart disease; Implantable cardioverter defibrillator; Implantation techniques; Psychosocial problems; Young patients

Indexed keywords

ANTIARRHYTHMIC AGENT;

CONFERENCE PAPER; CONGENITAL HEART DISEASE; DEFIBRILLATOR; EXPERIENCE; FOLLOW UP; HEART ARRHYTHMIA; HUMAN; INFECTION; SOCIAL PSYCHOLOGY;

ADULT; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 38549106035     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.00953.x     Document Type: Conference Paper

References (15)

1. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. ACC/AHA/NSAPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2002 106 : 2145 2161.
2. Stefanelli CB, Bradly DJ, Leroy S, Dick II. M, Serwer GA, Fischbach PS. Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Cardiol 2002 6 : 235 244.
3. Walsh EP, Cecchin F. Recent advances in pacemaker and implantable defibrillator therapy for young patients. Curr Opin Cardiol 2004 19 : 91 96.
4. Cannon BC, Friedman RA, Fenrich AL, Fraser CD, McKenzie ED, Kertesz NJ. Innovative techniques for placement of implantable cardioverter-defibrillator leads in patients with limited venous access to the heart. Pacing Clin Electrophysiol 2006 29 : 181 187.
5. Bauersfeld U, Tomaske M, Dodge-Khatami A, Rahn M, Kellenberger C, Prêtre R. Initial experience with implantable cardioverter defibrillator systems using epicardial and pleural electrodes in pediatric patients. Ann Thorac Surg 2007 84 : 303 305.
6. Korte T, Köditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004 27 : 924 932.
7. Link MS, Hill SL, Cliff DL, Swygman CA, Foote CB, Homoud MK, Wang PJ, et al. Comparison of frequency of complications of implantable cardioverter- defibrillators in children versus adults. Am J Cardiol 1999 83 : 263 266.
8. Khairy P, Landzberg MJ, Gatzoulis MA, Mercier LA, Fernandes SM, Côté JM, Lavoie JP, et al, for the Epicardial Versus Endocardial pacing and Thromboembolic events (EVENT) Investigators. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: A Multicenter Study. Circulation 2006 113 : 2391 2397.
9. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004 : 15 : 72 76.
10. Cooper JM, Stephenson EA, Berul CI, Walsh EP, Epstein LM. Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults with congenital heart disease: Implications for implantation and management. J Cardiovasc Electrophysiol 2003 14 : 344 349.
11. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005 28 : 926 932.
12. Love BA, Barrett KS, Alexander ME, Bevilacqua LM, Epstein MR, Triedman JK, Walsh EP, et al. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2001 12 : 1097 1101.
13. DeMaso DR, Lauretti A, Spieth L, van der Feen JR, Jay KS, Gauvreau K, Walsh EP, et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol 2004 93 : 582 587.
14. Sears SE, Conti JB. Understanding implantable cardioverter defibrillator shocks and storms: Medical and psychosocial considerations for research and clinical care. Clin Cardiol 2003 26 : 107 111.
15. Stephenson EA, Cecchin F, Walsh EP, Berul CI. Utility of routine follow-up defibrillator threshold testing in congenital heart disease and pediatric populations. J Cardiovasc Electrophysiol 2005 16 : 69 73.